Long-term outcomes in pediatric-onset esophageal eosinophilia

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome 
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study
Is 9 more than 2 also in allergic airway inflammation?
Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis  Marc E. Rothenberg, MD, PhD, Ting Wen, PhD, Allison Greenberg, BA, Oral.
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Carol J. Henderson, PhD, RD, J. Pablo Abonia, MD, Eileen C
Allergy testing in predicting outcome of open food challenge to peanut
Carine Blanchard, PhD, Emily M
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults  Meghan F. Davis, PhD, Roger D. Peng, PhD,
What are the best outcome measurements for atopic eczema
The Management of Eosinophilic Esophagitis
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
News Beyond Our Pages Journal of Allergy and Clinical Immunology
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Pediatric patients with eosinophilic esophagitis: An 8-year follow-up
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis—or should we really say mastocytic esophagitis?  J. Pablo Abonia, MD, James P. Franciosi,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
What is an “eosinophilic phenotype” of asthma?
J. Pablo Abonia, MD, Ting Wen, PhD, Emily M
Autophagy: Nobel Prize 2016 and allergy and asthma research
News Beyond Our Pages Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Joseph D. Sherrill, PhD, Pei-Song Gao, MD, PhD, Emily M
Development and cross-sectional validation of the Childhood Asthma Control Test  Andrew H. Liu, MD, Robert Zeiger, MD, Christine Sorkness, PharmD, Todd.
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Lauren A. DiTommaso, BS, Chen E. Rosenberg, MD, Michael D
Advances in the approach to the patient with food allergy
News Beyond Our Pages Journal of Allergy and Clinical Immunology
A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children  Felicia A. Rabito, PhD, MPH, John C. Carlson,
Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L
John Leung, MD, Navneet Virk Hundal, MD, Aubrey J. Katz, MD, Wayne G
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Elizabeth T. Jensen, MPH, PhD, Jonathan T. Kuhl, BS, Lisa J
Risk of oral food challenges
Eosinophilic esophagitis treated with immunotherapy to dust mites
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis  Elizabeth T. Jensen,
A flow cytometry–based diagnosis of eosinophilic esophagitis
Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts  Susan L. Hefle, PhD, Terence J.
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Charles W. DeBrosse, MD, Margaret H. Collins, MD, Bridget K
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists  Michael Schatz, MD, MS, Christine.
Environmental factors and eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Dietary therapy for eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet  Jonathan M. Spergel, MD, PhD, Terri F. Brown-Whitehorn,
Carine Blanchard, PhD, Emily M
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis  David W. Morris, MD, Emily M. Stucke, BA, Lisa.
Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial  Jonathan M. Spergel,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Long-term outcomes in pediatric-onset esophageal eosinophilia Charles W. DeBrosse, MD, James P. Franciosi, MD, MS, MSCE, Eileen C. King, PhD, Bridget K. Buckmeier Butz, MHSA, Allison B. Greenberg, BA, Margaret H. Collins, MD, J. Pablo Abonia, MD, Amal Assa’ad, MD, Philip E. Putnam, MD, Marc E. Rothenberg, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 128, Issue 1, Pages 132-138 (July 2011) DOI: 10.1016/j.jaci.2011.05.006 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Identification and recruitment of study participants. After histologic review of esophageal biopsy specimens obtained between 1982 and 1999, patients were categorized as having rEoE (≥15 eosinophils/hpf) or CE (<15 eosinophils/hpf). A healthy control group was also identified. Patients were then invited to complete validated outcome metrics. Journal of Allergy and Clinical Immunology 2011 128, 132-138DOI: (10.1016/j.jaci.2011.05.006) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Clinical features of the control, CE, rEoE, and DxEoE cohorts. Patients completed metrics for dysphagia (MDQ), food allergy, and quality of life (SF-12). The percentage of patients in the control, CE, and rEoE cohorts reporting dysphagia and food allergy, as well as median quality of life, were calculated (A). Data were reanalyzed with the subgroup of DxEoE removed from the rEoE and CE cohorts and classified independently (B). Journal of Allergy and Clinical Immunology 2011 128, 132-138DOI: (10.1016/j.jaci.2011.05.006) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Reported rates of dysphagia and peak esophageal eosinophil counts. Logistic regression analysis and receiver operating characteristic curves were generated to identify the relationship between dysphagia and peak esophageal eosinophil counts. The blue line represents the relationship between eosinophil counts and the probability of having dysphagia. Journal of Allergy and Clinical Immunology 2011 128, 132-138DOI: (10.1016/j.jaci.2011.05.006) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions